CLINICAL_TRIALS
trial_result
· 2012-01-20
Clinical Trial Update: Study Evaluating The Safety Of Xyntha In Usual Care Settings [Phase 4]
Summary
Pfizer's Phase 4 safety study of Xyntha in usual care settings for Hemophilia A was terminated, with results posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Hemophilia A | Phase 4 | Status: TERMINATED | Results posted: 2012-01-20